From evidence to impact: Leveraging real-world evidence to drive value in pricing and market access

Real-world evidence (RWE) is transforming pharma pricing and market access (P&MA) strategies - but are you leveraging its full potential? As healthcare systems increasingly demand robust, real-world data to support pricing and reimbursement decisions, understanding how to strategically employ RWE is more critical than ever.

Join the next episode of the Simon-Kucher Better Market Access webinar series for exclusive insights from our latest industry benchmarking study on RWE and academic collaboration.

This webinar will cover:

• How RWE is employed across the drug lifecycle, from clinical development to market entry and post-launch applications
• The clinical uncertainties RWE can help address and its role in supporting both short- and long-term strategic P&MA objectives
• Insights into how key European HTA bodies…